179 related articles for article (PubMed ID: 32105065)
1. A Luminescent Mg-Metal-Organic Framework for Sustained Release of 5-Fluorouracil: Appropriate Host-Guest Interaction and Satisfied Acid-Base Resistance.
Hu Z; Qiao C; Xia Z; Li F; Han J; Wei Q; Yang Q; Xie G; Chen S; Gao S
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14914-14923. PubMed ID: 32105065
[TBL] [Abstract][Full Text] [Related]
2. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
3. Investigation of Metal-Organic Framework-5 (MOF-5) as an Antitumor Drug Oridonin Sustained Release Carrier.
Chen G; Luo J; Cai M; Qin L; Wang Y; Gao L; Huang P; Yu Y; Ding Y; Dong X; Yin X; Ni J
Molecules; 2019 Sep; 24(18):. PubMed ID: 31527488
[TBL] [Abstract][Full Text] [Related]
4. Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.
Yang B; Shen M; Liu J; Ren F
Pharm Res; 2017 Nov; 34(11):2440-2450. PubMed ID: 28887609
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
6. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
[TBL] [Abstract][Full Text] [Related]
7. A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells.
Abazari R; Ataei F; Morsali A; Slawin AMZ; L Carpenter-Warren C
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45442-45454. PubMed ID: 31718155
[TBL] [Abstract][Full Text] [Related]
8. Elucidating the Drug Release from Metal-Organic Framework Nanocomposites via In Situ Synchrotron Microspectroscopy and Theoretical Modeling.
Souza BE; Donà L; Titov K; Bruzzese P; Zeng Z; Zhang Y; Babal AS; Möslein AF; Frogley MD; Wolna M; Cinque G; Civalleri B; Tan JC
ACS Appl Mater Interfaces; 2020 Jan; 12(4):5147-5156. PubMed ID: 31904920
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of functional hollow microspheres constructed from MOF shells: Promising drug delivery systems with high loading capacity and targeted transport.
Gao X; Hai X; Baigude H; Guan W; Liu Z
Sci Rep; 2016 Nov; 6():37705. PubMed ID: 27876876
[TBL] [Abstract][Full Text] [Related]
10. Guest-host interactions of nanoconfined anti-cancer drug in metal-organic framework exposed by terahertz dynamics.
Souza BE; Rudić S; Titov K; Babal AS; Taylor JD; Tan JC
Chem Commun (Camb); 2019 Mar; 55(27):3868-3871. PubMed ID: 30801075
[TBL] [Abstract][Full Text] [Related]
11. Magnetic bio-metal-organic framework nanocomposites decorated with folic acid conjugated chitosan as a promising biocompatible targeted theranostic system for cancer treatment.
Nejadshafiee V; Naeimi H; Goliaei B; Bigdeli B; Sadighi A; Dehghani S; Lotfabadi A; Hosseini M; Nezamtaheri MS; Amanlou M; Sharifzadeh M; Khoobi M
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():805-815. PubMed ID: 30889755
[TBL] [Abstract][Full Text] [Related]
12. MOF-801 as a Nanoporous Water-Based Carrier System for In Situ Encapsulation and Sustained Release of 5-FU for Effective Cancer Therapy.
Parsaei M; Akhbari K
Inorg Chem; 2022 Apr; 61(15):5912-5925. PubMed ID: 35377632
[TBL] [Abstract][Full Text] [Related]
13. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
[TBL] [Abstract][Full Text] [Related]
14. A γ-cyclodextrin-based metal-organic framework embedded with graphene quantum dots and modified with PEGMA via SI-ATRP for anticancer drug delivery and therapy.
Jia Q; Li Z; Guo C; Huang X; Song Y; Zhou N; Wang M; Zhang Z; He L; Du M
Nanoscale; 2019 Nov; 11(43):20956-20967. PubMed ID: 31660562
[TBL] [Abstract][Full Text] [Related]
15. Carboxymethylcellulose-coated 5-fluorouracil@MOF-5 nano-hybrid as a bio-nanocomposite carrier for the anticancer oral delivery.
Javanbakht S; Hemmati A; Namazi H; Heydari A
Int J Biol Macromol; 2020 Jul; 155():876-882. PubMed ID: 31805324
[TBL] [Abstract][Full Text] [Related]
16. pH-Responsive metal-organic framework encapsulated gold nanoclusters with modulated release to enhance photodynamic therapy/chemotherapy in breast cancer.
Zhang L; Gao Y; Sun S; Li Z; Wu A; Zeng L
J Mater Chem B; 2020 Feb; 8(8):1739-1747. PubMed ID: 32030386
[TBL] [Abstract][Full Text] [Related]
17. Hollow structural metal-organic frameworks exhibit high drug loading capacity, targeted delivery and magnetic resonance/optical multimodal imaging.
Gao X; Cui R; Song L; Liu Z
Dalton Trans; 2019 Nov; 48(46):17291-17297. PubMed ID: 31714562
[TBL] [Abstract][Full Text] [Related]
18. Photo-triggered release of 5-fluorouracil from a MOF drug delivery vehicle.
Roth Stefaniak K; Epley CC; Novak JJ; McAndrew ML; Cornell HD; Zhu J; McDaniel DK; Davis JL; Allen IC; Morris AJ; Grove TZ
Chem Commun (Camb); 2018 Jul; 54(55):7617-7620. PubMed ID: 29926872
[TBL] [Abstract][Full Text] [Related]
19. Metal organic framework-based polymeric hydrogel: A promising drug delivery vehicle for the treatment of breast cancer.
Pandya I; Kumar S; Aswal VK; El Seoud O; Assiri MA; Malek N
Int J Pharm; 2024 Jun; 658():124206. PubMed ID: 38734276
[TBL] [Abstract][Full Text] [Related]
20. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
